BioNovelus Announces the New Board of Directors
SCOTTSDALE, AZ -- May 11, 2016 -- InvestorsHub NewsWire --
BioNovelus, Inc. (PINKSHEETS:
ONOV) is pleased to announce its new Board of Directors. On May
3, 2016, the company held its quarterly Board of Directors meeting
with the majority of shareholders present.
All four of our newest Board members embody the spirit of
sustainability: People, Planet, and Profit, and bring talent,
expertise, energy and passion to the table., says Jean Ekobo,
President/CEO of BioNovelus.
New board members elected for two years include:
Jean Ekobo Chairman of the Board, and President & CEO of
BioNovelus, Inc.
Marvin Clark interim Treasurer
Nathalie Ekobo Secretary
Joss Francheterre Board member at-large.
Mark Johnson and James Perrine Advisory Board Members.
Other matters taken up at the board meeting:
A new transfer Agent is appointed.
The new transfer Agent is Nevada Agency and Transfer Company.
BioNovelus has retained the Law firm of Ryley Carlock &
Applewhite,
--------------------------------
About BioNovelus Inc.
BioNovelus, Inc. (PINKSHEETS:
ONOV) is a biotech company that honors the environment with an
innovative, cost effective, and disruptive technology-based
solution to the problems of safety and cleanliness regarding food
production and water supply.
------------------------------------------------------------------------------------------------
Additional Information
For additional information: http://bionovelus.com
Please contact: Nathalie Ekobo,
Marketing & Communications Director
BioNovelus, Inc.:
Skype: bionovelus.inc
+1 602-888-3424
NEkobo@BioNovelus.com
Forward-Looking Statements
This news release includes forward-looking statements covered by
the Private Securities Litigation Reform Act of 1995. Because such
statements deal with future events, they are subject to various
risks and uncertainties and actual results for fiscal year 2015 and
beyond could differ materially from the Company's current
expectations. Forward-looking statements are identified by words
such as "anticipates," "projects," "expects," "plans," "intends,"
"believes," "estimates," "targets," and other similar expressions
that indicate trends and future events.
Factors that could cause the Company's results to differ
materially from those expressed in forward-looking statements
include, without limitation, variation in demand and acceptance of
the Company's products and services, the frequency, magnitude and
timing of paper and other raw-material-price changes, general
business and economic conditions beyond the Company's control,
timing of the completion and integration of acquisitions, the
consequences of competitive factors in the marketplace including
the ability to attract and retain customers, results of continuous
improvement and other cost-containment strategies, and the
Company's success in attracting and retaining key personnel. The
Company undertakes no obligation to revise or update
forward-looking statements as a result of new information, since
these statements may no longer be accurate or timely.
Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933, and are subject to Rule 3B-6 under the
Securities Exchange Act of 1934, and are subject to the safe harbor
created by those rules. All statements, other than statements of
fact, included in this press release, including, without
limitation, statements regarding potential future plans and
objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and other results and
further events could differ materially from those anticipated in
such statements. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying
the forward-looking statements.
SOURCE: BioNovelus Inc.